Insider · CIK 0001278388
Neal C Bradsher
Files at STAA (STAAR SURGICAL CO), LCTX (Lineage Cell Therapeutics, Inc.), IMDX (Oncocyte Corp). First filing -, latest -.
In brief
Neal C Bradsher files SEC Form 4 as 10% owner and director at STAA (STAAR SURGICAL CO), and also at LCTX (Lineage Cell Therapeutics, Inc.), IMDX (Oncocyte Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Neal C Bradsher has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award OPTION TO PURCHASE COMMON SHARESderivative | +125,000 | $0.00 | $0 | 125,000 | Jul 2, 2026 |
| Jun 18, 2026 | STAA STAAR SURGICAL CO | AGrant or award OPTION TO PURCHASE COMMON STOCKderivative | +11,145 | $0.00 | $0 | 11,145 | Jun 22, 2026 |
| Mar 6, 2026 | STAA STAAR SURGICAL CO | AGrant or award OPTION TO PURCHASE COMMON STOCKderivative | +7,524 | $0.00 | $0 | 7,524 | Mar 10, 2026 |
| Jul 1, 2025 | LCTX Lineage Cell Therapeutics, Inc. | AGrant or award OPTION TO PURCHASE COMMON SHARESderivative | +75,000 | $0.00 | $0 | 75,000 | Jul 3, 2025 |
Questions about Neal C Bradsher
Answered from the filings on this page, as of the latest one.
Is Neal C Bradsher buying or selling?
Neal C Bradsher has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Neal C Bradsher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neal C Bradsher has 0.
Where does Neal C Bradsher file Form 4?
Neal C Bradsher has filed Form 4 at STAA (STAAR SURGICAL CO); LCTX (Lineage Cell Therapeutics, Inc.); IMDX (Oncocyte Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.